As of January 22, 2025, Eisai (4523.T) has a market cap of $8.01 billion USD. According to our data, Eisai is ranked No.1971 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $8.01 B |
2.13%
|
Dec 30, 2024 | $7.85 B |
-36.93%
|
Dec 29, 2023 | $12.44 B |
-17.32%
|
Dec 30, 2022 | $15.04 B |
36.71%
|
Dec 30, 2021 | $11.00 B |
-9.64%
|
Dec 30, 2020 | $12.18 B |
-8.45%
|
Dec 30, 2019 | $13.30 B |
-0.86%
|
Dec 31, 2018 | $13.42 B |
34.99%
|
Dec 29, 2017 | $9.94 B |
-1.89%
|
Dec 30, 2016 | $10.13 B |
-14.93%
|
Dec 30, 2015 | $11.91 B |
75.76%
|
Dec 30, 2014 | $6.78 B |
18.83%
|
Dec 30, 2013 | $5.70 B |
17.32%
|
Dec 28, 2012 | $4.86 B |
18.06%
|
Dec 30, 2011 | $4.12 B |
13.75%
|
Dec 30, 2010 | $3.62 B |
-10.00%
|
Dec 30, 2009 | $4.02 B |
-3.51%
|
Dec 30, 2008 | $4.17 B |
-12.85%
|
Dec 28, 2007 | $4.78 B |
-31.14%
|
Dec 29, 2006 | $6.95 B |
34.76%
|
Dec 30, 2005 | $5.15 B |
49.53%
|
Dec 31, 2004 | $3.45 B |
18.14%
|
Dec 31, 2003 | $2.92 B |
9.93%
|
Dec 31, 2002 | $2.65 B |
-17.38%
|
Dec 31, 2001 | $3.21 B |
-17.81%
|
Dec 29, 2000 | $3.91 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.38 B |
0.002 M
|
UK
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Takeda Pharmaceutical
TAK
|
$41.01 B |
-0.002 M
|
Japan
|
Biogen
BIIB
|
$20.80 B |
-0.001 M
|
USA
|
Market Cap | = | 4523.T Stock Price | * | 4523.T Shares Outstanding |
= | $28.42 | * | 0.28 B | |
= | $8.01 B |